Navigation Links
New Research Shows: Neurofeedback is an 'Evidence-Based' Treatment for ADHD
Date:7/15/2009

NIJMEGEN, The Netherlands, July 16 /PRNewswire/ -- Neurofeedback - also called EEG Biofeedback - is a method used to train brain activity in order to normalize Brain function and treat psychiatric disorders. This treatment method has gained interest over the last 10 years, however the question whether this treatment should be regarded as an Evidence-Based treatment was unanswered until now. Tomorrow a study will be published in the scientific journal 'EEG and Clinical Neuroscience' demonstrating that Neurofeedback can indeed be regarded as an evidence-based treatment for Attention Deficit- / Hyperactivity Disorder (ADHD).

Neurofeedback is a treatment where real-time feedback is provided for specific brain activity (most often EEG) in order to learn the brain to suppress or produce specific brain activity. This method was initially discovered for the treatment of Epilepsy and from 1976 investigated further for the treatment of ADHD. This technique has become more popular by clinicians worldwide, and is currently provided for the treatment of several disorders. Critics have often questioned the efficacy of Neurofeedback and whether it can be considered an Evidence Based treatment or not.

In collaboration with researchers from Tubingen University (Germany), Radboud University (Nijmegen, the Netherlands), Brainclinics and EEG Resource Institute a so-called meta-analysis was conducted on all published research about Neurofeedback treatment in ADHD. This meta-analysis included 15 studies and 1194 ADHD patients. Based on this study - which will be published in the July issue of EEG and Clinical Neuroscience - it could be concluded that Neurofeedback can indeed be considered an Evidence-Based treatment for ADHD. The results show that neurofeedback treatment has large and clinically significant effects on Impulsivity and Inattention and a modest improvement of Hyperactivity.

These findings apply to Neurofeedback treatment for ADHD, but do not automatically imply that Neurofeedback can be considered evidence based for any disorder. The efficacy of Neurofeedback has to be assessed separately for each disorder. For example, a meta-analysis of EEG biofeedback in Epilepsy is published in the same issue of EEG and Clinical Neuroscience demonstrating clinical efficacy in the treatment of epilepsy.

Interested clients are advised to make an informed choice regarding Neurofeedback therapists, since there is a large heterogeneity in neurofeedback treatment approaches and clinicians. It is advised to look for psychologists or physicians who are a member of a professional organization such as the International Society for Neurofeedback and Research (ISNR: http://www.isnr.org) or other professional organizations.

Literature

Arns, M., de Ridder, S., Strehl, U., Breteler, M. & Coenen, A. Efficacy of Neurofeedback Treatment in ADHD: The effects on Inattention, Impulsivity and Hyperactivity: a Meta-Analysis. EEG and Clinical Neuroscience; 40(3), 180-189.

http://www.brainclinics.com

Brainclinics is specialized in Personalized Medicine, applied Neuroscience and diagnostics of Brain related disorders. Furthermore, Brainclinics is specialized in innovative new - evidence-based - treatments such as rTMS for Depression and Neurofeedback for the treatment of ADHD. Employing applied Brain research Brainclinics strives to improve and personalize treatments in order to achieve more efficacious clinical outcomes (also called Personalized Medicine).


'/>"/>
SOURCE Brainclinics Treatment B.V.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2019)... ... April 17, 2019 , ... Lillibridge ... of the nation’s largest owners and operators of medical office buildings (MOBs), will ... experts during the Building Owners and Managers Association (BOMA) International Medical Office Buildings ...
(Date:4/17/2019)... ... ... Clinical trials of new cancer treatments have historically focused on disease type by tumor ... oncology and genomic characterization of tumors, we are now able to test new therapies ... ability has created a paradigm shift in oncology trials. , In basket trials, cancers ...
(Date:4/17/2019)... ... April 17, 2019 , ... Women’s Excellence in Obstetrics and Gynecology ... a health concern, you want to be seen by a provider. We believe ... to their normal routine as soon as possible.” Dr. Jonathan Zaidan, MD, FACOG, President ...
Breaking Medicine Technology:
(Date:4/17/2019)... ... April 17, 2019 , ... Historically, patients ... reluctance appears to be changing. Whether because of demographic or generational changes, patients ... healthcare providers advice. , In the past, efforts to publish performance data about ...
(Date:4/17/2019)... NEW HAVEN, Conn. (PRWEB) , ... April 17, ... ... patient community for IBS sufferers, announced a new initiative this April to designate ... Patients and to show strong support for research & healthcare professionals in their ...
(Date:4/17/2019)... ... 2019 , ... On May 3, Kyle Marcelli will return to Mid-Ohio ... IMSA Continental Tire SportsCar Challenge race in 2018, Kyle Marcelli and ... their #60 KohR Motorsports / Roush Performance Ford Mustang GT4 across the ...
(Date:4/17/2019)... ... April 17, 2019 , ... Signaled.online is a notification service designed for personal ... of the web resources and reminder. , The alarm can be useful while traveling ... If you haven’t logged in to the website for several days (this period is ...
(Date:4/17/2019)... (PRWEB) , ... April 17, 2019 , ... Tune in ... of Women’s Excellence who overcame infertility and endometriosis with robotic surgery. Hosts Dr. ... benefits of robotic surgery for patients and the impact robotic surgery can have on ...
Breaking Medicine News(10 mins):